Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.74	40.58	22.35	32.55	45.75	74.59
Short-Term Investments	-	-	80.4	65.34	-	-
Cash & Short-Term Investments	31.74	40.58	102.75	97.89	45.75	74.59
Cash Growth	-63.57%	-60.51%	4.96%	113.99%	-38.67%	660.53%
Prepaid Expenses	2.17	2.45	2.07	2.94	2.17	1.32
Total Current Assets	33.91	43.03	104.82	100.83	47.92	75.92
Property, Plant & Equipment	20.42	21.33	35.28	4.47	5.86	4.47
Other Long-Term Assets	1.99	1.99	2.5	4.67	1.09	0.45
Total Assets	56.32	66.35	142.6	109.97	54.87	80.83
Accounts Payable	0.73	1.18	3.13	2.62	3.13	0.92
Accrued Expenses	2.25	2.11	8.14	8.37	3.63	2.83
Current Portion of Leases	4.24	4.12	5.43	1.55	1.07	0.99
Current Unearned Revenue	0.22	0.4	1.66	1.28	9.79	-
Other Current Liabilities	4.04	4.82	1.23	0.66	0.63	0.15
Total Current Liabilities	11.47	12.63	19.6	14.47	18.25	4.88
Long-Term Leases	29.11	30.26	21.45	0.67	0.38	1.45
Long-Term Unearned Revenue	11.86	11.86	12.14	14.08	1.93	-
Total Liabilities	52.44	54.75	53.18	29.21	20.55	6.34
Common Stock	0.07	0.07	0.06	0.03	0.01	0.01
Additional Paid-In Capital	417.14	416.32	400.69	329.39	227.7	224.36
Retained Earnings	-413.34	-404.79	-311.36	-248.68	-193.4	-149.88
Comprehensive Income & Other	-	-	0.03	0.01	-	-
Total Common Equity	3.87	11.59	89.42	80.75	34.32	74.49
Shareholders' Equity	3.87	11.59	89.42	80.75	34.32	74.49
Total Liabilities & Equity	56.32	66.35	142.6	109.97	54.87	80.83
Total Debt	33.36	34.38	26.88	2.22	1.45	2.44
Net Cash (Debt)	-1.62	6.2	75.87	95.68	44.29	72.15
Net Cash Growth	-	-91.83%	-20.70%	116.01%	-38.61%	1013.14%
Net Cash Per Share	-1.24	4.76	76.17	158.22	170.54	419.98
Filing Date Shares Outstanding	1.33	1.32	1.19	0.64	0.26	0.26
Total Common Shares Outstanding	1.32	1.31	1.14	0.64	0.26	0.26
Working Capital	22.44	30.39	85.22	86.36	29.67	71.03
Book Value Per Share	2.94	8.85	78.14	126.86	131.91	288.01
Tangible Book Value	3.87	11.59	89.42	80.75	34.32	74.49
Tangible Book Value Per Share	2.94	8.85	78.14	126.86	131.91	288.01
Machinery	4.89	4.89	3.4	5.35	5.59	3.58
Construction In Progress	-	-	-	-	-	0.5
Leasehold Improvements	0.49	0.49	0.46	0.4	2.11	0.32

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q